Cassiopea SpA - ESG Rating & Company Profile powered by AI
The dashboard includes a Q&A table on Cassiopea SpA. This report of Cassiopea SpA incorporates data points from across the internet as well as from public documents by Cassiopea SpA. Alternative companies in the rating industry group for Cassiopea SpA are shown below.
Cassiopea SpA in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 6.8; made up of an environmental score of 6.0, social score of 8.0 and governance score of 6.4.
6.8
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 294 | SMS Pharmaceuticals Ltd | 6.9 | High |
| 294 | Takeda Pharmaceutical Co Ltd | 6.9 | High |
| 314 | Cassiopea SpA | 6.8 | High |
| 314 | Camurus AB | 6.8 | High |
| 314 | Alpine Immune Sciences Inc | 6.8 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Cassiopea SpA have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Cassiopea SpA disclose current and historical energy intensity?
Sign up for free to unlockDoes Cassiopea SpA report the average age of the workforce?
Sign up for free to unlockDoes Cassiopea SpA reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Cassiopea SpA disclose its ethnicity pay gap?
Sign up for free to unlockDoes Cassiopea SpA disclose cybersecurity risks?
Sign up for free to unlockDoes Cassiopea SpA offer flexible work?
Sign up for free to unlockDoes Cassiopea SpA have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Cassiopea SpA disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Cassiopea SpA conduct supply chain audits?
Sign up for free to unlockDoes Cassiopea SpA disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Cassiopea SpA conduct 360 degree staff reviews?
Sign up for free to unlockDoes Cassiopea SpA disclose the individual responsible for D&I?
Sign up for free to unlockDoes Cassiopea SpA disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Cassiopea SpA disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Cassiopea SpA disclose water use targets?
Sign up for free to unlockDoes Cassiopea SpA have careers partnerships with academic institutions?
Sign up for free to unlockDid Cassiopea SpA have a product recall in the last two years?
Sign up for free to unlockDoes Cassiopea SpA disclose incidents of discrimination?
Sign up for free to unlockDoes Cassiopea SpA allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Cassiopea SpA issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Cassiopea SpA disclose parental leave metrics?
Sign up for free to unlockDoes Cassiopea SpA disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Cassiopea SpA disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Cassiopea SpA disclose the pay ratio of women to men?
Sign up for free to unlockDoes Cassiopea SpA support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Cassiopea SpA disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Cassiopea SpA reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Cassiopea SpA involved in embryonic stem cell research?
Sign up for free to unlockDoes Cassiopea SpA disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Cassiopea SpA disclose its waste policy?
Sign up for free to unlockDoes Cassiopea SpA report according to TCFD requirements?
Sign up for free to unlockDoes Cassiopea SpA disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Cassiopea SpA disclose energy use targets?
Sign up for free to unlockDoes Cassiopea SpA disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Cassiopea SpA have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Cassiopea SpA
These potential risks are based on the size, segment and geographies of the company.
Cassiopea S.p.A., a clinical-stage specialty pharmaceutical company, focuses on developing and commercializing medical dermatology products worldwide. It offers Winlevi, an antiandrogen, which has completed Phase III clinical trial for the topical treatment of acne; Breezula, a topical antiandrogen that is in Phase II clinical trial to treat androgenic alopecia; CB-06-01, a topical antibiotic, which is in Phase II clinical trial for the treatment of acne, including strains resistant to other antibiotics; and CB-06-02, a novel integrin activator that has completed Phase II clinical trial to treat genital warts. The company was formerly known as Cosmo Dermatos S.r.l. Cassiopea S.p.A. was founded in 2013 and is based in Lainate, Italy. As of December 2, 2021, Cassiopea S.p.A. operates as a subsidiary of Cosmo Pharmaceuticals N.V.